CTLT vs DERM
CTLT (CTLT) versus Journey Medical Corp (DERM) — a side-by-side from cached financials, not a winner call.
CTLT (CTLT) common stock.
Journey Medical Corp (DERM) is a drug manufacturers - specialty & generic company listed on US.
CTLT does not have a complete income-statement cache yet.
Latest reported DERM revenue for 2024-12-31 was $56.1M. Net income was -$14.7M. Revenue was down 29.1% from 2023-12-31 to 2024-12-31. DERM currently screens at market cap $163.1M.
DERM currently screens at market cap $163.1M.
Not investment advice. Open the CTLT and DERM stock pages for the full models.
Not investment advice.